Biocon pharmaceuticals, one of India’s pharmaceutical major has reported 3% less profits at Rs.97.8 crore for Q4 of FY 2012 which ended on March 31st; main reason being zero licensing income during this quarter. Company’s revenues though showed a positive trend with an increase by 25% in the quarter to Rs.611.5 crore from Rs.487.9 crore […]
Continue Reading...